Please login to the form below

Not currently logged in
Email:
Password:

Idis

This page shows the latest Idis news and features for those working in and with pharma, biotech and healthcare.

Quantum Pharma confirms Clinigen takeover bid

Quantum Pharma confirms Clinigen takeover bid

In 2015 it bought Idis for £225m to gain a firmer foothold in the $5bn unlicensed medicines market and in clinical trial supply.

Latest news

  • Clinigen acquires Idis for £225m Clinigen acquires Idis for £225m

    Acquisition makes them the global leader in unlicensed medicines.  . Clinigen Group is to acquire unlicensed medicines supplier Idis for £225m. ... Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes

  • Langland triumphs at IPA Best of Health Awards Langland triumphs at IPA Best of Health Awards

    Windsor, UK agency wins Best of Show for Idis campaign.  . Langland continued its recent awards success by picking up Best of Show for advertising to healthcare processionals at the IPA Best ... year at the IPA event, where its campaign for Idis swept

  • Langland steals the pharma show at first Lions Health Langland steals the pharma show at first Lions Health

    four silver prizes for its work for Idis.  .

  • VCCP Health takes lead at PM Society Awards VCCP Health takes lead at PM Society Awards

    There were prizes for work for AbbVie and IDIS for Langland; Becton, Dickinson &Company and AstraZeneca for Saatchi &Saatchi Health; and Teva Europe and Napp for Woolley Pau Gyro. ... Crestor for AstraZeneca by Saatchi &Saatchi Health (Joint Winner). I

  • Langland leads Global Award winners Langland leads Global Award winners

    A major integrated campaign by Langland also won the Grand Global award in the Professional Healthcare category for its work for Idis. ... And winning the Grand Global for our work for Idis is a real honour,” said Langland chief executive Philip Chin.

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Quintiles president Jeff Thomis to chair Idis Former Quintiles president Jeff Thomis to chair Idis

    Idis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access programmes for medicines. ... As specialists in the field, Idis is strongly placed to deliver highly effective solutions to our customers who

  • Suzanne Gagnon joins Idis as CMO Suzanne Gagnon joins Idis as CMO

    She was formerly chief medical officer at Icon. Idis has appointed Dr Suzanne Gagnon as its first chief medical officer. ... Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics